Combinatorial treatment of bone marrow stem cells and stromal cell-derived factor 1 improves glycemia and insulin production in diabetic mice

Molecular and Cellular Endocrinology

Volumn 345, Issue 1-2, 2011, Pages 88-96

  Cheng, H ^a   Zhang, Y C ^b   Wolfe, S ^b   Valencia, V ^b   Qian, K ^b   Shen, L ^b   Tang, Y L ^c   Hsu, W H ^d   Atkinson, M A ^e   Phillips, M I ^c  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c KECK GRADUATE INSTITUTE   (United States)

^d IOWA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Bone marrow stem cells; Diabetes; Homing; Insulin; Liver; SDF 1

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; INSULIN DERIVATIVE; INSULIN I; INSULIN II; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL HOMING; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; ENDOCRINE CELL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INSULIN BLOOD LEVEL; INSULIN SYNTHESIS; LIVER CELL; MOUSE; NONHUMAN; PANCREAS CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; BODY WEIGHT; BONE MARROW CELLS; C-PEPTIDE; CELL DIFFERENTIATION; CHEMOKINE CXCL12; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; STEM CELL TRANSPLANTATION; STEM CELLS; SURVIVAL ANALYSIS;

EID: 80052621726     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.07.024     Document Type: Article

References (58)

1. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
2. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 1996, 184:1101-1109.
3. Blyszczuk P., Czyz J., Kania G., Wagner M., Roll U., St Onge L., Wobus A.M. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc. Natl. Acad. Sci. USA 2003, 100:998-1003.
4. Bonner-Weir S., Taneja M., Weir G.C., Tatarkiewicz K., Song K.H., Sharma A., O'Neil J.J. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 2000, 97:7999-8004.
5. Broxmeyer H.E., Kohli L., Kim C.H., Lee Y., Mantel C., Cooper S., Hangoc G., Shaheen M., Li X., Clapp D.W. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J. Leukoc. Biol. 2003, 73:630-638.
6. Cao L.Z., Tang D.Q., Horb M.E., Li S.W., Yang L.J. High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells. Diabetes 2004, 53:3168-3178.
7. Cheng H., Beck A., Launay P., Gross S.A., Stokes A.J., Kinet J.P., Fleig A., Penner R. TRPM4 controls insulin secretion in pancreatic beta-cells. Cell Calcium 2007, 41:51-61.
8. Choi J.B., Uchino H., Azuma K., Iwashita N., Tanaka Y., Mochizuki H., Migita M., Shimada T., Kawamori R., Watada H. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 2003, 46:1366-1374.
9. Gao R., Ustinov J., Pulkkinen M.A., Lundin K., Korsgren O., Otonkoski T. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 2003, 52:2007-2015.
10. Gefen-Halevi S., Rachmut I.H., Molakandov K., Berneman D., Mor E., Meivar-Levy I., Ferber S. NKX6.1 promotes PDX-1-induced liver to pancreatic β-cells reprogramming. Cell Reprogram. 2010, 12:655-664.
11. Gupta S.K., Lysko P.G., Pillarisetti K., Ohlstein E., Stadel J.M. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 1998, 273:4282-4287.
12. Hasegawa Y., Ogihara T., Yamada T., Ishigaki Y., Imai J., Uno K., Gao J., Kaneko K., Ishihara H., Sasano H., Nakauchi H., Oka Y., Katagiri H. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology 2007, 148:2006-2015.
13. Hatch H.M., Zheng D., Jorgensen M.L., Petersen B.E. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 2002, 4:339-351.
14. Herzog E.L., Chai L., Krause D.S. Plasticity of marrow-derived stem cells. Blood 2003, 102:3483-3493.
15. Hess D., Li L., Martin M., Sakano S., Hill D., Strutt B., Thyssen S., Gray D.A., Bhatia M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 2003, 21:763-770.
16. Hill W.D., Hess D.C., Martin-Studdard A., Carothers J.J., Zheng J., Hale D., Maeda M., Fagan S.C., Carroll J.E., Conway S.J. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 2004, 63:84-96.
17. Hori Y., Rulifson I.C., Tsai B.C., Heit J.J., Cahoy J.D., Kim S.K. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc. Natl. Acad. Sci. USA 2002, 99:16105-16110.
18. Houghton J., Stoicov C., Nomura S., Rogers A.B., Carlson J., Li H., Cai X., Fox J.G., Goldenring J.R., Wang T.C. Gastric cancer originating from bone marrow-derived cells. Science 2004, 306:1568-1571.
19. Huang Y., Kucia M., Hussain L.R., Wen Y., Xu H., Yan J., Ratajczak M.Z., Ildstad S.T. Bone marrow transplantation temporarily improves pancreatic function in streptozotocin-induced diabetes: potential involvement of very small embryonic-like cells. Transplantation 2010, 89:677-685.
20. Ianus A., Holz G.G., Theise N.D., Hussain M.A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 2003, 111:843-850.
21. Jahr H., Bretzel R.G. Insulin-positive cells in vitro generated from rat bone marrow stromal cells. Transplant. Proc. 2003, 35:2140-2141.
22. Ji J.F., He B.P., Dheen S.T., Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 22:415-427.
23. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
24. Kahan B.W., Jacobson L.M., Hullett D.A., Ochoada J.M., Oberley T.D., Lang K.M., Odorico J.S. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes 2003, 52:2016-2024.
25. Kaneto H., Nakatani Y., Miyatsuka T., Matsuoka T.A., Matsuhisa M., Hori M., Yamasaki Y. PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes 2005, 54:1009-1022.
26. Kania G., Blyszczuk P., Czyz J., Navarrete-Santos A., Wobus A.M. Differentiation of mouse embryonic stem cells into pancreatic and hepatic cells. Methods Enzymol. 2003, 365:287-303.
27. Kayali A.G., Van Gunst K., Campbell I.L., Stotland A., Kritzik M., Liu G., Flodstrom-Tullberg M., Zhang Y.Q., Sarvetnick N. The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J. Cell Biol. 2003, 163:859-869.
28. Kodama S., Kuhtreiber W., Fujimura S., Dale E.A., Faustman D.L. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003, 302:1223-1227.
29. Kollet O., Shivtiel S., Chen Y.Q., Suriawinata J., Thung S.N., Dabeva M.D., Kahn J., Spiegel A., Dar A., Samira S., Goichberg P., Kalinkovich A., Arenzana-Seisdedos F., Nagler A., Hardan I., Revel M., Shafritz D.A., Lapidot T. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest. 2003, 112:160-169.
30. Lapidot T., Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 2002, 30:973-981.
31. Lavazais E., Pogu S., Sai P., Martignat L. Cytokine mobilization of bone marrow cells and pancreatic lesion do not improve streptozotocin-induced diabetes in mice by transdifferentiation of bone marrow cells into insulin-producing cells. Diabetes Metab. 2007, 33:68-78.
32. Lee R.H., Seo M.J., Reger R.L., Spees J.L., Pulin A.A., Olson S.D., Prockop D.J. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 2006, 103:17438-17443.
33. Li W.C., Horb M.E., Tosh D., Slack J.M. In vitro transdifferentiation of hepatoma cells into functional pancreatic cells. Mech. Dev. 2005, 122:835-847.
34. Lumelsky N., Blondel O., Laeng P., Velasco I., Ravin R., McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001, 292:1389-1394.
35. Mathews V., Hanson P.T., Ford E., Fujita J., Polonsky K.S., Graubert T.A. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004, 53:91-98.
36. Miyazaki S., Yamato E., Miyazaki J. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 2004, 53:1030-1037.
37. Nagasawa T., Kikutani H., Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor 2. Proc. Natl. Acad. Sci. USA 1994, 91:2305-2309.
38. Noguchi H. Production of pancreatic beta-cells from stem cells. Curr. Diabetes Rev. 2010, 6:184-190.
39. Oh S.H., Muzzonigro T.M., Bae S.H., LaPlante J.M., Hatch H.M., Petersen B.E. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab. Invest. 2004, 84:607-617.
40. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben Hur H., Many A., Shultz L., Lider O., Alon R., Zipori D., Lapidot T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
41. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., Ponomaryov T., Taichman R.S., Arenzana-Seisdedos F., Fujii N., Sandbank J., Zipori D., Lapidot T. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 2002, 3:687-694.
42. Pillarisetti K., Gupta S.K. Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 2001, 25:293-300.
43. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
44. Ramiya V.K., Maraist M., Arfors K.E., Schatz D.A., Peck A.B., Cornelius J.G. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med. 2000, 6:278-282.
45. Ratajczak M.Z., Majka M., Kucia M., Drukala J., Pietrzkowski Z., Peiper S., Janowska-Wieczorek A. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003, 21:363-371.
46. Sapir T., Shternhall K., Meivar-Levy I., Blumenfeld T., Cohen H., Skutelsky E., Eventov-Friedman S., Barshack I., Goldberg I., Pri-Chen S., Ben-Dor L., Polak-Charcon S., Karasik A., Shimon I., Mor E., Ferber S. Cell-replacement therapy for diabetes: generating functional insulin-producing tissue from adult human liver cells. Proc. Natl. Acad. Sci. USA 2005, 102:7964-7969.
47. Seaberg R.M., Smukler S.R., Kieffer T.J., Enikolopov G., Asghar Z., Wheeler M.B., Korbutt G., van der K.D. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 2004, 22:1115-1124.
48. Sipione S., Eshpeter A., Lyon J.G., Korbutt G.S., Bleackley R.C. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 2004, 47:499-508.
49. Sordi V. Mesenchymal stem cell homing capacity. Transplantation 2009, 87:S42-S45.
50. Stoffel M., Vallier L., Pedersen R.A. Navigating the pathway from embryonic stem cells to beta cells. Semin. Cell Dev. Biol. 2004, 15:327-336.
51. Tang D.Q., Cao L.Z., Burkhardt B.R., Xia C.Q., Litherland S.A., Atkinson M.A., Yang L.J. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004, 53:1721-1732.
52. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., Fairbairn L.J., Bellantuono I. A small proportion of mesenchymal stem cells strongly express functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 2004, 104:2643-2645.
53. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D.W., Isner J.M., Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
54. Yang L., Li S., Hatch H., Ahrens K., Cornelius J.G., Petersen B.E., Peck A.B. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. USA 2002, 99:8078-8083.
55. Yang L. Liver stem cell-derived β-cell surrogates for treatment of type 1 diabetes. Autoimmun. Rev. 2005, 5:409-413.
56. Zalzman M., Gupta S., Giri R.K., Berkovich I., Sappal B.S., Karnieli O., Zern M.A., Fleischer N., Efrat S. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc. Natl. Acad. Sci. USA 2003, 100:7253-7258.
57. Zhou Y., Larsen P.H., Hao C., Yong V.W. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem. 2002, 277:49481-49487.
58. Zulewski H., Abraham E.J., Gerlach M.J., Daniel P.B., Moritz W., Muller B., Vallejo M., Thomas M.K., Habener J.F. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001, 50:521-533.